<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>66(Pt 8)</volume><submitter>Feng G</submitter><pubmed_abstract>The title compound, C(32)H(40)O(10), also known as xyloccensin L [systematic name: (1R,4aR,4bS,5aR,6aR,9R,10S,10aS,10bR,2aR,13R)-1-(furan-3-yl)-6a-hy-droxy-10-(2-meth-oxy-2-oxoeth-yl)-9,10a,12a-trimethyl-3-oxododeca-hydro-1H,3H,5aH-6,9-methano-isochromeno[6,5-f]oxireno[g]chromen-13-yl (2E)-2-methyl-but-2-enoate], is a limonoid with a C1-C29 oxygen bridge: this is the first report of the X-ray crystal structure of such a limonoid. Two fused pyran rings and two cyclo-hexane rings adopt boat conformations, while another cyclo-hexane ring and the d-lactone ring are in half-chair conformations. The mol-ecular structure is stabilized by intra-molecular O-H⋯O hydrogen bonding.</pubmed_abstract><journal>Acta crystallographica. Section E, Structure reports online</journal><pagination>o2111-2</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3007225</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Xyloccensin L.</pubmed_title><pmcid>PMC3007225</pmcid><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Satyanandamurty T</pubmed_authors><pubmed_authors>Feng G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Xyloccensin L.</name><description>The title compound, C(32)H(40)O(10), also known as xyloccensin L [systematic name: (1R,4aR,4bS,5aR,6aR,9R,10S,10aS,10bR,2aR,13R)-1-(furan-3-yl)-6a-hy-droxy-10-(2-meth-oxy-2-oxoeth-yl)-9,10a,12a-trimethyl-3-oxododeca-hydro-1H,3H,5aH-6,9-methano-isochromeno[6,5-f]oxireno[g]chromen-13-yl (2E)-2-methyl-but-2-enoate], is a limonoid with a C1-C29 oxygen bridge: this is the first report of the X-ray crystal structure of such a limonoid. Two fused pyran rings and two cyclo-hexane rings adopt boat conformations, while another cyclo-hexane ring and the d-lactone ring are in half-chair conformations. The mol-ecular structure is stabilized by intra-molecular O-H⋯O hydrogen bonding.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Jul</publication><modification>2025-04-18T19:27:26.883Z</modification><creation>2019-03-27T00:00:36Z</creation></dates><accession>S-EPMC3007225</accession><cross_references><pubmed>21588402</pubmed><doi>10.1107/S1600536810028527</doi></cross_references></HashMap>